DXB 0.00% 51.0¢ dimerix limited

why not try reading stuff that's out there, like...

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    why not try reading stuff that's out there, like this
    https://www.fdanews.com/articles/208909-fda-declines-traveres-second-attempt-at-accelerated-approval-for-sparsentan
    and this
    https://ir.travere.com/news-releases/news-release-details/travere-completes-successful-pre-nda-meeting-filspari-igan

    #trevere completed the largest ever phase3 trialy in fsg called "duplex". better phase2 data than the dimx asset
    #excellent statistically significant interim result on proteinuria in phase3. FDA still said no to accelerated. Twice.
    #the reasoning is laid bare. only a complete fool with head buried in sand thinks none of this is relevant
    #what's so special about the dimx asset that make you think FDA will give them free pass to accelerated? I just don't see it. other ccr2 inhibitor from CSL failed in its fsg trial, no better than placebo
    https://newsroom.csl.com/2020-05-18-VFMCRP-Press-Release-Phase-ii-Lumina-1-Trial-of-Ccx140
    #question if this method of action is that effective in fsg disease but we'll know for certain once dimx phase3 finishes in few years



 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
51.0¢
Change
0.000(0.00%)
Mkt cap ! $280.6M
Open High Low Value Volume
51.5¢ 54.5¢ 51.0¢ $1.715M 3.301M

Buyers (Bids)

No. Vol. Price($)
7 365433 51.0¢
 

Sellers (Offers)

Price($) Vol. No.
51.5¢ 19658 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.